Shares of Precipio Inc (NASDAQ:PRPO) traded up 16.1% during trading on Wednesday . The stock traded as high as $0.78 and last traded at $0.52. 234,462 shares were traded during mid-day trading, an increase of 31% from the average session volume of 178,325 shares. The stock had previously closed at $0.62.
Separately, ValuEngine upgraded Precipio from a “strong sell” rating to a “sell” rating in a report on Friday, December 1st.
The company has a current ratio of 0.08, a quick ratio of 0.07 and a debt-to-equity ratio of 0.01.
ILLEGAL ACTIVITY WARNING: This article was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.thelincolnianonline.com/2018/03/14/precipio-prpo-trading-up-16-1.html.
Precipio Company Profile
Precipio, Inc, formerly Transgenomic, Inc, is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.